Skip to main content
Caplight Logo









OstomyCure AS

OstomyCure AS

Private
OsloHealthcare & Life Scienceshttps://ostomysecure.com/

Last Round

Early Funding

Jul 1, 2026

Total Funding Raised

$5.68M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

OstomyCure AS is a medical technology company that develops and markets the TIES® System, a titanium implant solution designed to replace conventional ileostomy bags for patients with stomas.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

medical implantostomystoma bag alternativecolostomyTranscutaneous Implant Evacuation SystemTIESsurgical devicestoma caregastroenterologymedical deviceostomy suppliestitanium implantclinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OstomyCure AS Comparables

Compare OstomyCure AS with similar companies based on industry and business-model similarity.

OstomyCure AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OriVa
82%
Implantica AG
79%
Ampa Medical
79%

OstomyCure AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 1, 2026
GrantFeb 20, 2019
GrantJan 1, 2019

Key People

Founding team and executive leadership

Graeme L. Smith

Chief Executive Officer, Executive Chair

Executive Team

OstomyCure AS Investors

Notable investors and investment history

OstomyCure AS investors
InvestorRounds
European CommissionGrant
KistefosEarly Funding, Private Equity
Inven2Private Equity, Early Funding
CanicaPrivate Equity, Early Funding
Innovasjon NorgeGrant, Private Equity
The Research Council of NorwayGrant, Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 66% MoM, reaching 2.7K.

  • Jul 1, 2026

    $14.3M raised from Canica, Kistefos, and Inven2.

OstomyCure AS Filings

Explore SEC and related filing metadata, where available.

OstomyCure AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OstomyCure AS's valuation, stock price, and market status.

Is OstomyCure AS a public or private company?

OstomyCure AS is a private company.

What is the current stock price of OstomyCure AS?

OstomyCure AS is a private company with no public stock price. No recent secondary market data is available.

How much is OstomyCure AS worth (valuation)?

Valuation information for OstomyCure AS is not publicly available.

Can I buy OstomyCure AS stock?

OstomyCure AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OstomyCure AS's last funding round?

OstomyCure AS's most recent funding round was Early Funding on July 1, 2026.

Who are the main investors in OstomyCure AS?

Key investors in OstomyCure AS include Kistefos.

Will OstomyCure AS IPO soon?

No public IPO plans have been announced for OstomyCure AS.

How can I track OstomyCure AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OstomyCure AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range8
Year Founded2004
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?